Cargando…
Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical Device
Clofazimine (CFZ) is a poorly soluble, weakly basic, small molecule antibiotic clinically used to treat leprosy and is now in clinical trials as a treatment for multidrug resistant tuberculosis and COVID-19. CFZ exhibits complex, context-dependent pharmacokinetics that are characterized by an increa...
Autores principales: | Dunne, Steven, Willmer, Andrew R., Swanson, Rosemary, Almeida, Deepak, Ammerman, Nicole C., Stringer, Kathleen A., Capparelli, Edmund V., Rosania, Gus R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780429/ https://www.ncbi.nlm.nih.gov/pubmed/35056910 http://dx.doi.org/10.3390/pharmaceutics14010015 |
Ejemplares similares
-
Reverse Engineering the Intracellular Self-Assembly of a Functional Mechanopharmaceutical Device
por: Woldemichael, Tehetina, et al.
Publicado: (2018) -
An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of Clofazimine
por: Willmer, Andrew R., et al.
Publicado: (2021) -
Acoustic tweezing cytometry for mechanical phenotyping of macrophages and mechanopharmaceutical cytotripsy
por: Hong, Xiaowei, et al.
Publicado: (2019) -
Distinguishing the Concentration- vs. Bioaccumulation-Dependent Immunological and Metabolic Effects of Clofazimine
por: Willmer, Andrew R., et al.
Publicado: (2023) -
Clofazimine-Mediated, Age-Related Changes in Skeletal Muscle Mitochondrial Metabolites
por: Diaz-Espinosa, Jennifer, et al.
Publicado: (2023)